MedTrace Logo

PSC Clinical Epidemiology in China

NCT04981756 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-05-26

No results posted yet for this study

Summary

Primary sclerosing cholangitis (PSC) is a rare disease but is increasingly reported in China (mainly in the Chinese language). However, most of the PSC literatures reported from China are case reports, small case series, and review articles. Up to now, there is no information on the epidemiology and disease burden of PSC in China. This study would use EMR/HIS and research databases to investigate the epidemiology, cascade, and treatment pattern of PSC in China.

Conditions

  • Primary Sclerosing Cholangitis

Interventions

OTHER

observation

This observational study does not have any intervention.

Sponsors & Collaborators

  • Beijing YouAn Hospital

    collaborator OTHER

  • Shanghai Suvalue Health Scientific Ltd.

    collaborator UNKNOWN

  • The First Hospital of Jilin University

    collaborator OTHER

  • Beijing Ditan Hospital

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER

  • Second Hospital of Jilin University

    collaborator OTHER

  • Hepatobiliary Disease Hospital of Jilin Province

    collaborator UNKNOWN

  • Lanzhou University Second Hospital

    collaborator OTHER

  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER

  • Beijing Friendship Hospital

    lead OTHER

Principal Investigators

  • Jidong Jia, MD, PhD · Beijing Friendship Hospital, Capital Medical University, Beijing, China

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-07
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04981756 on ClinicalTrials.gov